FRASCOTTI GIANNI
- U04, Piano: 4, Stanza: 4022
Pubblicazioni
Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES [10.1021/acsami.5c06626]. Dettaglio
Tomaino, G., Pantaleoni, C., D'Urzo, A., Santambrogio, C., Testa, F., Ciprandi, M., et al. (2024). An Efficient Method for Vault Nanoparticle Conjugation with Finely Adjustable Amounts of Antibodies and Small Molecules. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25(12) [10.3390/ijms25126629]. Dettaglio
Tomaino, G., Pantaleoni, C., Ami, D., Pellecchia, F., Dutriaux, A., Barbieri, L., et al. (2023). Addressing Critical Issues Related to Storage and Stability of the Vault Nanoparticle Expressed and Purified from Komagataella phaffi. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(4) [10.3390/ijms24044214]. Dettaglio
Tomaino, G., Dutriaux, A., Flagiello, D., Tortora, P., Frascotti, G., Prosperi, D., et al. (2023). Recombinant vault nanoparticle: a potential tool for the targeted delivery of siRNA as therapeutic molecules. Intervento presentato a: 20th International Conference on Nanosciences & Nanotechnologies (NN23) July 4-7, 2023, Thessaloniki, Greece. Dettaglio
Frascotti, G., Galbiati, E., Mazzucchelli, M., Pozzi, M., Salvioni, L., Vertemara, J., et al. (2021). The vault nanoparticle: A gigantic ribonucleoprotein assembly involved in diverse physiological and pathological phenomena and an ideal nanovector for drug delivery and therapy. CANCERS, 13(4), 1-37 [10.3390/cancers13040707]. Dettaglio